1. Home
  2. ACET vs RGS Comparison

ACET vs RGS Comparison

Compare ACET & RGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$8.26

Market Cap

79.9M

Sector

Health Care

ML Signal

HOLD

Logo Regis Corporation

RGS

Regis Corporation

N/A

Current Price

$28.39

Market Cap

72.7M

ML Signal

N/A

Company Overview

Basic Information
Metric
ACET
RGS
Founded
1947
1922
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
79.9M
72.7M
IPO Year
2017
1994

Fundamental Metrics

Financial Performance
Metric
ACET
RGS
Price
$8.26
$28.39
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$48.33
N/A
AVG Volume (30 Days)
83.8K
5.1K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
20.24
EPS
N/A
0.89
Revenue
N/A
$210,134,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$31.51
Revenue Growth
N/A
3.52
52 Week Low
$0.46
$18.76
52 Week High
$9.84
$31.50

Technical Indicators

Market Signals
Indicator
ACET
RGS
Relative Strength Index (RSI) 46.13 49.05
Support Level $7.45 $25.96
Resistance Level $8.68 $28.44
Average True Range (ATR) 0.52 1.06
MACD -0.06 -0.00
Stochastic Oscillator 31.47 48.73

Price Performance

Historical Comparison
ACET
RGS

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. It is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. The company's main product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, and is being developed for the potential treatment of autoimmune diseases. Additionally, it is pursuing ADI-212, a next-generation gene-edited and armored clinical candidate designed to target prostate-specific membrane antigen (PSMA).

About RGS Regis Corporation

Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.

Share on Social Networks: